|Karo Pharma AB -- USA Stock|| |
USD 4.10 0.43 11.75%
Member of the Board, Employee Representative
Mr. Bo Carlsson has served as Director Employee Representative of Karo Bio AB since 1997. He joined the Company in 1997. He works as Senior Research Scientist. He completed a Specialist Teacher Exam at Uppsala Universitet.
Age: 59 Executive Since 1997
46 86 08 60 00 http://www.karobio.com
The company has return on total asset (ROA)
of 4.14 %
which means that it generated profit of $4.14 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 16.6 %
meaning that it generated $16.6 on every $100 dollars invested by stockholders.
The company has accumulated 77.45 M in total debt with debt to equity ratio (D/E) of 58.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karo Pharma AB has Current Ratio of 2.06 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Karo Pharma AB , a pharmaceutical company, develops various drugs in Sweden. Karo Pharma AB (KARBF) is traded on OTC Market in USA. It is located in Stockholm, and employs 39 people.